sever
acut
respiratori
syndrom
coronaviru
novel
betacoronaviru
first
describ
cluster
patient
present
pneumonia
symptom
wuhan
china
decemb
two
previou
epidem
caus
betacoronavirus
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
presag
potenti
anoth
betacoronaviru
like
caus
widespread
pandem
time
first
paper
document
novel
coronaviru
infect
publish
januari
infect
spread
patient
evid
persontoperson
transmiss
well
intern
case
past
month
diseas
caus
coronaviru
diseas
covid
becom
worldwid
pandem
case
global
sinc
emerg
infecti
diseas
yet
pauciti
data
effect
infect
patient
congenit
heart
diseas
aim
summar
initi
experi
consid
potenti
applic
implic
patient
congenit
heart
diseas
base
data
influenza
viral
infect
previou
coronaviru
epidem
sar
mer
viral
infect
mainli
caus
pulmonari
issu
like
pneumonia
acut
respiratori
distress
syndrom
said
virus
shown
caus
direct
myocardi
injuri
known
case
myocard
caus
influenza
coronavirus
furthermor
patient
underli
heart
diseas
congenit
acquir
seem
increas
morbid
mortal
relat
viral
infect
strong
recommend
vaccin
influenza
prevent
poor
outcom
also
data
suggest
patient
underli
heart
diseas
may
suscept
contract
coronaviru
infect
betacoronavirus
abl
infect
human
host
angiotensin
convert
enzym
fig
membranebound
protein
express
mani
human
cell
includ
vascular
endothelia
renal
tissu
cardiovascular
tissu
small
intestin
epithelia
base
studi
investig
sar
mer
coronavirus
shown
back
circul
bat
coronavirus
potenti
human
emerg
use
human
receptor
host
cell
phylogenet
analysi
demonstr
novel
betacoronaviru
similar
receptor
bind
domainmotif
sar
coronaviru
suggest
use
receptor
enter
human
cell
recent
genet
sequenc
analysi
show
similar
sar
similar
mer
coronaviru
make
seventh
member
coronaviru
famili
infect
human
well
third
coronaviru
bat
origin
shown
transmit
via
humantohuman
contact
estim
r
betacoronavirus
mainli
infect
epitheli
cell
lung
detect
respiratori
fecal
blood
specimen
patient
infect
viru
spread
droplet
contact
entri
ocular
tissu
fecal
shed
seen
patient
week
onset
symptom
unclear
correl
infect
sinc
also
express
intestin
epithelia
live
viru
detect
stool
patient
transmiss
via
fecalor
rout
theoret
possibl
confirm
epidemiolog
studi
yet
viru
remain
viabl
aerosol
h
certain
surfac
h
viru
detect
day
prior
symptom
onset
upper
respiratori
sampl
median
incub
period
estim
day
ci
day
thought
mainli
spread
via
asymptomat
carrier
make
contain
diseas
difficult
substanti
undocu
infect
asymptomat
infect
individu
may
explain
rapid
geograph
spread
one
case
report
highlight
patient
underw
postmortem
autopsi
patholog
analysi
studi
shown
caus
direct
damag
pneumocyt
via
viral
cytopath
effect
also
caus
acut
respiratori
distress
syndrom
ard
character
diffus
alveolar
damag
direct
damag
heart
tissu
note
one
patient
data
multipl
studi
show
inflammatori
marker
increas
infect
rang
crp
posit
contribut
sustain
inflammatori
respons
cytokin
storm
fig
lymphopenia
commonli
seen
patient
critic
ill
suggest
viral
particl
invad
lymphocyt
caus
target
destruct
cell
summar
caus
direct
damag
lung
epithelia
lead
sever
pneumonia
ard
viru
also
caus
inflammatori
respons
infect
patient
may
lead
multiorgan
failur
dissemin
intravascular
coagul
dic
certain
patient
furthermor
hypoxia
seen
patient
sever
pneumonia
ard
may
also
lead
endorgan
dysfunctiondamag
death
criticallyil
patient
appear
two
clinic
stage
diseas
first
stage
replic
stage
replic
cours
sever
day
patient
present
rel
mild
symptom
unlik
human
coronaviru
infect
commonli
present
upper
respiratori
symptom
like
rhinorrhea
one
studi
show
sizeabl
proport
patient
infect
may
exhibit
symptom
symptomat
patient
present
fever
dri
cough
short
breath
find
pneumonia
chest
xray
comput
tomographi
scan
chest
symptomat
patient
suffer
mild
respiratori
infect
requir
support
care
like
supplement
oxygen
patient
also
develop
gastrointestin
symptom
like
abdomin
pain
nausea
diarrhea
mention
earlier
lymphopenia
seen
commonli
patient
may
poor
prognost
factor
second
stage
adapt
immun
stage
bodi
develop
antibodi
respons
viru
lead
fall
titer
viru
resolut
symptom
patient
minor
patient
howev
becom
criticallyil
high
risk
mortal
around
patient
worsen
diseas
requir
intens
care
tabl
suffer
ard
viremia
acut
cardiac
injuri
multiorgan
failur
secondari
bacteri
infect
multiorgan
dysfunct
believ
secondari
mark
immun
inflammatori
respons
may
result
cardiac
injuri
via
multipl
mechan
fig
may
caus
cardiac
injuri
indirectli
due
overwhelm
immun
inflammatori
respons
cytokin
storm
viral
invas
cardiomyocyt
direct
damag
via
process
proven
patholog
studi
sever
hypoxia
acut
respiratori
damag
caus
viru
may
result
oxid
stress
myocardi
injuri
increas
myocardi
oxygen
demand
presenc
sever
hypoxia
due
acut
lung
injuri
ard
furthermor
express
heart
viru
use
enzym
receptor
entri
cell
unclear
time
howev
bind
alter
express
caus
dysregul
raa
reninangiotensinaldosteron
system
pathway
mechan
cardiac
injuri
fulli
describ
data
document
effect
cardiovascular
system
two
studi
cardiac
injuri
manifest
increas
troponin
level
found
admit
patient
tabl
uncommon
find
overal
cardiac
injuri
common
criticallyil
patient
two
studi
criticallyil
patient
demonstr
n
patient
develop
cardiac
injuri
n
patient
develop
cardiomyopathi
anoth
tabl
summari
studi
document
among
group
patient
n
elev
troponin
level
n
ntermin
pro
btype
natriuret
peptid
level
n
detect
signal
cardiovascular
injuri
one
analysi
patient
die
demonstr
patient
two
differ
time
point
death
group
patient
die
around
day
onset
diseas
anoth
group
die
around
day
onset
author
hypothes
initi
group
die
respiratori
failur
second
group
myocardi
damag
signific
cardiovascular
collaps
concern
myocard
case
report
document
clinic
myocard
consist
previou
report
myocard
caus
coronavirus
includ
mer
given
increas
elev
cytokin
level
note
patient
sever
infect
well
observ
patient
deterior
rapidli
multiorgan
failur
cardiogen
shock
studi
perform
investig
possibl
role
fulmin
myocard
patient
contract
recov
develop
sever
critic
ill
unfortun
multipl
studi
shown
patient
underli
cardiovascular
comorbid
hypertens
coronari
arteri
diseas
like
suffer
sever
infect
requir
icu
care
complic
like
ard
turn
may
result
death
one
studi
show
patient
infect
underli
hypertens
increas
odd
death
ci
p
b
compar
without
hypertens
similarli
coronari
arteri
diseas
associ
increas
odd
ci
p
b
death
one
metaanalysi
patient
hypertens
rel
risk
ratio
ci
p
b
sever
diseas
requir
icu
care
compar
without
hypertens
patient
coronari
arteri
diseasecerebrovascular
diseas
rel
risk
ratio
ci
p
b
sever
diseaserequir
icu
care
compar
without
cardiovascular
diseas
analyz
largest
case
seri
date
confirm
case
chines
center
diseas
control
prevent
report
patient
cardiovascular
diseas
case
fatal
rate
hypertens
case
fatal
rate
higher
overal
case
fatal
rate
fig
patient
hypertens
account
case
compris
death
patient
cardiovascular
diseas
made
case
respons
death
fig
may
due
fact
patient
histori
coronari
arteri
diseas
acut
coronari
syndrom
may
reduc
impair
cardiovascular
function
reserv
infect
may
either
precipit
myocardi
infarct
type
myocardi
infarct
increas
myocardi
demand
lead
worsen
ischemia
necrosi
type
myocardi
infarct
increas
metabol
demand
lead
heart
failur
death
case
seri
patient
heart
transplant
infect
appear
although
patient
immunosuppress
seem
similar
outcom
compar
patient
without
heart
transplant
infect
number
patient
small
n
thu
result
obvious
extrapol
larger
popul
remark
howev
heart
transplant
patient
hubei
provinc
three
infect
speak
import
proper
hygien
social
distanc
public
health
measur
date
publish
report
patient
congenit
heart
diseas
infect
albeit
bound
come
limit
data
detail
effect
pediatr
popul
review
case
chines
center
diseas
control
prevent
show
case
children
younger
year
old
base
singl
epidemiolog
studi
pediatr
patient
evalu
treat
case
confirm
via
rtpcr
test
children
age
infect
median
age
year
rang
day
year
infect
pediatr
patient
male
compar
adult
patient
children
diagnos
seem
less
sever
diseas
case
mild
moder
natur
young
children
especi
infant
howev
seem
suscept
sever
diseas
older
children
patient
year
age
sever
critic
diseas
death
seri
yearold
male
anoth
studi
children
year
age
assess
test
posit
infect
median
age
infect
children
year
patient
symptom
sign
pneumonia
three
children
requir
intens
care
mechan
ventilatori
support
preexist
medic
condit
lymphopenia
present
patient
child
histori
intussuscept
die
multiorgan
failur
death
studi
third
studi
examin
children
age
year
group
patient
test
posit
median
age
infect
patient
year
old
rang
year
none
infect
children
comorbid
six
pediatr
patient
fever
cough
diagnosi
well
lymphopenia
one
patient
requir
intens
care
unit
icu
admiss
mortal
mechan
children
seem
less
suscept
sever
infect
caus
yet
elucid
theoriz
bind
protein
children
function
adult
thu
less
infecti
none
studi
describ
children
congenit
heart
diseas
thu
effect
viru
specif
patient
popul
clear
nevertheless
children
seem
less
vulner
adult
overal
review
pregnant
women
infect
reveal
pregnant
women
increas
risk
poor
outcom
compar
gener
adult
popul
seem
evid
vertic
transmiss
viru
mother
babi
birth
breastfeed
present
women
gave
birth
cesarean
section
data
vertic
transmiss
women
infect
earlier
pregnanc
deliv
vagin
studi
clearli
warrant
examin
potenti
impact
pregnanc
date
publish
studi
adult
patient
congenit
heart
diseas
thu
current
manag
strategi
extrapol
known
effect
adult
patient
adult
patient
cardiovascular
diseas
said
effort
way
adult
congenit
heart
associ
intern
societi
adult
congenit
heart
diseas
gather
data
number
suspect
confirm
case
unit
state
global
better
understand
outcom
popul
absenc
data
help
guid
care
difficult
make
definit
recommend
howev
sensibl
step
taken
await
build
evid
base
patient
congenit
heart
diseas
suspect
first
step
confirm
diseas
nasopharyng
swab
rtpcr
recommend
initi
test
sensit
clinic
suspicion
high
enough
ct
chest
may
warrant
proper
isol
measur
taken
provid
wear
appropri
person
protect
equip
regardless
diagnost
test
note
case
neg
initi
test
later
repeat
posit
may
due
low
viral
titer
earli
infect
one
shock
realiti
mani
countri
includ
western
nation
like
unit
state
lack
widespread
test
capabl
time
write
manuscript
third
week
march
test
lo
angel
woefulli
unavail
vast
major
potenti
infect
patient
drivethrough
test
avail
day
inhospit
test
limit
highest
risk
subset
situat
must
remedi
quickli
us
realist
chanc
account
track
degre
spread
viru
patient
underli
cardiovascular
comorbid
increas
risk
morbid
mortal
infect
studi
far
detail
granular
fashion
risk
individu
cardiovascular
complic
patient
underli
cardiovascular
diseas
infect
studi
includ
patient
congenit
heart
diseas
stand
reason
patient
congenit
heart
diseas
could
consid
higher
risk
complic
certain
adult
patient
congenit
heart
diseas
achd
like
higher
risk
other
base
achd
anatomi
physiolog
stage
classif
patient
complex
congenit
heart
diseas
anatomi
stage
iii
physiolog
stage
b
c
symptom
could
consid
high
risk
complic
relat
infect
basi
decreas
function
reserv
tabl
reduc
immun
includ
syndrom
digeorg
syndrom
asplenia
may
even
higher
risk
poor
outcom
infect
studi
tri
riskstratifi
patient
suffer
viral
pneumonia
mulbsta
score
may
tool
provid
use
see
patient
high
risk
decompens
death
sinc
patient
underli
cardiovascular
diseas
higher
risk
morbid
mortal
patient
achd
take
great
care
prevent
infect
includ
frequent
handwash
social
distanc
measur
proper
appropri
use
mask
person
protect
equip
clean
disinfect
commonli
touch
surfac
patient
congenit
heart
diseas
vaccin
influenza
pneumococc
pneumonia
possibl
regularli
schedul
clinic
visit
convert
telehealth
visit
minim
risk
acquir
infect
nosocomi
set
desir
minim
risk
infect
must
obvious
weigh
necess
inperson
visit
patient
eg
decompens
congest
heart
failur
arrhythmia
advent
wearabl
technolog
wide
avail
blood
pressur
heart
rate
oximetri
equip
home
use
reason
substitut
inclin
vital
sign
measur
addit
video
function
allow
clinician
inspect
patient
visual
albeit
far
less
comprehens
manner
compar
tradit
physic
examin
handheld
easili
steril
echocardiograph
equip
also
handi
substitut
tradit
comprehens
echocardiographi
inevit
higher
rate
exposur
frequent
visit
echo
lab
least
short
term
social
distanc
approach
practic
clinic
medicin
suffic
major
patient
earli
experi
telehealth
ucla
achd
clinic
posit
abl
safe
diminish
physic
clinic
walkthrough
volum
patient
achd
diagnos
manag
infect
similar
gener
popul
patient
close
chines
experi
manag
expectantli
home
selfcar
measur
initi
data
unit
state
similar
estim
patient
hospit
need
admit
treatment
mainli
support
follow
world
health
organ
guidelin
manag
symptomat
relief
antipyret
use
supplement
oxygen
manag
comorbid
condit
cornerston
therapi
use
antivir
immun
modul
antibiot
therapi
point
consid
standard
care
control
trial
ongo
anxious
await
result
recommend
treatment
patient
may
experi
cardiac
injuri
arrhythmia
employ
echocardiographi
cardiac
enzym
would
seem
paramount
set
myocardi
injuri
may
occur
due
varieti
mechan
direct
viral
invas
cardiomyocyt
hypoxia
due
sever
pneumonia
lead
ischem
cardiac
tissu
overwhelm
inflammatori
respons
lead
cytokin
storm
myocardi
dysfunct
fig
lead
troponin
leak
elev
brain
natriuret
peptid
bnp
laboratori
assess
cardiac
injuri
recommend
routin
basi
patient
show
sign
symptom
myocardi
injuri
stsegment
chang
electrocardiogram
exampl
acut
coronari
syndrom
chest
pain
unstabl
arrhythmia
heart
failur
evalu
thoroughli
differenti
normal
cardiac
function
increas
metabol
demand
acut
coronari
syndrom
fulmin
myocard
import
clinic
scenario
requir
differ
treatment
algorithm
patient
deterior
judici
use
fluid
resuscit
vasopressor
mechan
ventil
extracorpor
membran
oxygen
ecmo
success
support
patient
critic
ill
use
steroid
recommend
gener
treatment
report
patient
recov
fulmin
myocard
intraven
immunoglobulin
steroid
studi
need
help
pars
patient
benefit
therapi
term
medic
treatment
option
current
studi
variou
stage
develop
relat
treatment
clinicaltrialsgov
access
march
given
novel
natur
viru
known
effect
therapi
time
therapi
studi
includ
antivir
remdesivir
lopinavirritonavir
chloroquin
hydroxychloroquin
antiinflammatori
tocilizumab
steroid
agent
trial
publish
far
assess
use
lopinavirritonavir
adult
hospit
therapi
show
benefit
beyond
standard
care
mani
therapi
cardiovascular
side
effect
howev
caution
must
use
appli
patient
congenit
heart
diseas
vaccin
develop
also
underway
one
prioriti
move
forward
patient
suffer
cardiovascular
complic
requir
either
percutan
surgic
intervent
case
must
assess
individu
basi
institut
develop
protocol
appropri
triag
isol
treatment
patient
may
need
intervent
china
prefer
use
thrombolyt
therapi
patient
acut
coronari
syndrom
ie
stelev
myocardi
infarct
standard
care
unit
state
pandem
progress
resourc
start
becom
strain
may
ask
ration
certain
measur
intens
care
unit
bed
mechan
ventil
extracorpor
support
sincer
hope
come
major
countri
concern
underscor
dire
import
slow
spread
allow
health
care
system
appropri
prepar
manag
crisi
without
resort
ration
highest
level
care
importantli
clinic
need
imag
invas
surgic
intervent
must
weigh
risk
infect
healthcar
worker
may
lack
appropri
person
protect
equip
point
time
standard
oper
procedur
use
person
protect
equip
steril
catheter
lab
oper
room
also
develop
viru
use
receptor
enter
infect
cell
sinc
express
mani
tissu
includ
vascular
endothelium
cardiac
tissu
hypothes
use
aceinhibitor
angiotensin
receptor
blocker
arb
may
effect
cours
inactiv
angiotensin
ii
gener
angiotensin
potent
vasodil
anim
model
arb
shown
increas
cardiac
express
chronic
day
treatment
base
studi
origin
sar
coronaviru
viral
bind
lead
downregul
result
excess
product
angiotensin
ii
angiotensin
convert
enzym
ace
decreas
quantiti
vasodil
heptapeptid
angiotensin
contribut
lung
injuri
stimul
raa
pathway
counterintuit
arb
increas
number
receptor
tabl
adult
congenit
patient
like
higher
risk
poor
outcom
due
impair
function
reserv
adapt
accaha
guidelin
achd
patient
patient
congenit
heart
diseas
regardless
complex
anatomi
avail
bind
overal
effect
arb
may
protect
lung
injuri
reduc
angiotensin
ii
product
ace
increas
product
vasodil
angiotensin
effect
aceinhibitor
arb
patient
covid
yet
known
remain
unproven
studi
requir
recommend
made
start
withdraw
aceinhibitor
arb
medic
heart
failur
societi
america
american
colleg
cardiolog
american
heart
associ
releas
statement
recommend
continu
raa
inhibitor
patient
current
take
indic
agent
known
benefici
heart
failur
hypertens
ischem
heart
diseas
posit
also
echo
european
societi
cardiolog
global
pandem
caus
begin
number
peopl
infect
viru
increas
exponenti
rate
studi
current
document
infect
patient
congenit
heart
diseas
highli
like
case
diagnos
worldwid
alreadi
number
congenit
heart
diseas
patient
infect
imper
individu
program
concert
region
nation
global
organ
work
togeth
ensur
data
gather
number
patient
test
diagnos
infect
outcom
congenit
cardiolog
program
need
readi
enrol
patient
studi
registri
trial
word
winston
churchil
never
worri
action
inact
need
meticul
studi
diseas
voraci
appetit
learn
secret
tireless
effort
combat
spread
author
report
relationship
could
constru
conflict
interest
